← SynDRA
OTENZEPAD
SynDRA canonical compound SYN0000999 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | CHRM2 |
|---|
| Mechanism of action | Acetylcholine receptor antagonist |
|---|
All known targets
- CHRM2
- CHRM1
- CHRM3
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRM1 ANTAGONIST
- CHRM2 ANTAGONIST
- CHRM3 ANTAGONIST
- CHRM4 ANTAGONIST
- CHRM5 ANTAGONIST
Drug classes
- Anti-Arrhythmia Agents
- Parasympatholytics
Cross-references
Synonyms
- AF-DX-116
- 11-(2-(2-((Diethylamino)methyl)piperidin-1-yl)acetyl)-5H-benzo[e]pyrido[3,2-b][1,4]diazepin-6(11H)-one
- UNII-WW6A9TFL2C
- UNII-SX2WTG9R3Z
- WW6A9TFL2C
- SX2WTG9R3Z
- 11-[[2-[(DIETHYLAMINO)METHYL]-1-PIPERIDINYL]ACETYL]-5,11-DIHYDRO-6H-PYRIDO[2,3-B][1,4]BENZODIAZEPIN-6-ONE
- BRN 4212983
- CHEMBL17045
- NSC664529
- NCGC00025002-02
- DSSTox_RID_81048
- DSSTox_CID_25674
- DSSTox_GSID_45674
- 6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 11-((2-((diethylamino)methyl)-1-piperidinyl)acetyl)
- AF-DX 116
- OM7J0XAL0S
- otenzepadum
- RefChem:856990
- Otenzepad, (+)-
- Otenzepad [INN]
- afdx-116
- AF-DX-250
- Otenzepad, (-)-
- DTXCID8025674
- SMR000466280
- CAS-102394-31-0
- UNII-OM7J0XAL0S
- UBRKDAVQCKZSPO-UHFFFAOYSA-N
- AFDX116
- GTPL309
- MLS000758304
- MLS001424139
- SCHEMBL341879
- AF-DX 116 BS
- orb1307923
- SCHEMBL29363384
- SCHEMBL29482389
Look up OTENZEPAD in the interactive SynDRA portal →